Answers are grounded in this paper and cite their sources.
Develops advanced alginate-nutriosomes to optimize oral delivery of fermented Echium amoenum polyphenols, suggesting improved bioavailability.
Echium amoenum, a highly valued medicinal plant in Iran, is rich in polyphenols. Microbial fermentation can improve the bioavailability of its phenolic compounds, which are otherwise limited (5–10%), by releasing them from the plant cell wall. Moreover, incorporating these bioactive compounds in phospholipid vesicles can further maximize their biological efficacy. This study developed a combined approach using lactic acid fermentation with Lactiplantibacillus plantarum and phospholipid-based nanocarriers to optimize the delivery of E. amoenum extract. Fermented extract (50 mg/mL) was successfully incorporated into liposomes, nutriosomes, and advanced alginate-nutriosomes, as confirmed by cryo-TEM and FTIR analyses. All vesicles were nanosized (105–124 nm), negatively charged (~ − 56 mV), and homogeneously dispersed (PDI ≤ 0.19) with high loading efficiencies (> 90%). They remained stable under simulated saliva, gastric, and intestinal conditions and exhibited controlled release. In vitro assays demonstrated biocompatibility and protective effects on stressed Caco-2 cells. Overall, alginate-nutriosomes represent a promising nanocarrier for oral administration of fermented E. amoenum extract.
No takes yet. Share an insight, caveat, or question.
Khosroshahi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: